US Stock MarketDetailed Quotes

ADILW Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)

Watchlist
  • 0.0009
  • 0.00000.00%
Close Jul 28 09:30 ET
0Market Cap0.00P/E (TTM)

About Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com) Company

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

Company Profile

SymbolADILW
Company NameAdial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)
CEOMr. Cary J Claiborne
MarketNASDAQ
Employees20
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.adialpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • William B. Stilley, III,M.B.A.
  • Executive Vice President and Director; Chief Executive Officer of Purnovate, Inc.
  • 1.23M
  • Cary J Claiborne
  • Director, President and Chief Executive Officer
  • 466.76K
  • Dr. Bankole A. Johnson, D.Sc.,M.D.
  • Chief Medical Officer
  • 6.33K
  • Joseph Truluck, M.B.A.
  • Principal Accounting Officer, Chief Financial Officer, Treasurer and Secretary
  • 624.52K
  • Kevin Schuyler, C.F.A.,M.B.A.
  • Chairman of the Board and Lead Independent Director
  • 141.26K
  • Robertson H. Gilliland, M.B.A.
  • Independent Director
  • 138.26K
  • James W. Newman, Jr
  • Independent Director
  • 139.26K
  • J. Kermit Anderson
  • Independent Director
  • 136.26K
  • Tony Goodman
  • Independent Director
  • 142.26K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg